Mission Statement

Mission Statement

ACROSS-ACADEMY Medical Education programme has been established as a collaboration between leading international experts to share their knowledge and best clinical practice with colleagues who manage patients with Kidney or Metabolic and or Heart diseases.

CKD, T2D and HF conditions are progressive in nature and are interrelated. The presence of either one of these conditions can amplify risk and accelerate progression across the other conditions.1-3 The ACROSS-ACADEMY supports with foundational knowledge for diagnosing and the active management of patients with kidney or metabolic or heart diseases.

References

  1. Kalra S, Aydin H, Sahay M, et al. Cardiorenal syndrome in type 2 diabetes mellitus—rational use of sodium-glucose cotransporter-2 inhibitors. Eur Endocrinol. 2020;16(2):113-121.

  2. Leon BM, Maddox TM. Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes. 2015;6(13):1246-1258.

  3. Centers for Disease Control and Prevention. Chronic Kidney Disease (CKD) Surveillance System. Accessed December 9, 2022. https://nccd.cdc.gov/ckd/AreYouAware.aspx?emailDate=September_2019.